Back to ASCP Scientific Updates: Molecular Marker Testing Recommendations for Lung Cancer Treatment
ASCP Scientific Updates are a quarterly series of 30-minute on-demand webcasts containing up-to-the-minute information on various therapeutic agents, disease states, and thresholds that impact immuno-oncology diagnostics in solid tumors and hematologic malignancies.
This webcast addresses the latest molecular marker testing recommendations for lung cancer treatment.
The guidelines for non–small cell lung cancer (NSCLC) are changing quickly, with new updates and modifications of recommendations released in early 2018. To treat advanced stage lung cancer patients rapidly, it's important to stay up-to-date on the appropriate tests.
This course is designed to educate pathologists and laboratory personnel on the sensitive assays and new technologies involved in lung cancer testing. You will learn a general overall view of the current state of molecular testing in lung cancer. Additionally, you will learn about the exciting and evolving role of next generation sequencing (NGS) and circulating cfDNA (liquid biopsy) in lung cancer testing, as well as the limitations in small biopsies. The significant role of immunohistochemistry (IHC) for single-gene assessments, ALK, and ROS1 testing are also discussed. The course will help you understand the guidelines that will lead to more uniform testing in a clinically reliable way across the laboratory profession.
As a result of participating in this course, learners will be able to:
- Describe the changes in lung cancer testing and treatment happening at a rapid pace
- Discuss current lung cancer guidelines and recommendations, including the role of immunotherapy and PD-L1 testing
- Describe the roles of ALK, EGFR, and ROS1 testing in treatment decisions
- Discuss the roles and limitations of next generation sequencing (NGS) and liquid biopsy (cf-DNA) testing in lung cancers
Credit Designation Statement
The ASCP designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
These activities also meet CC Part II Lifelong Learning and Self-Assessment Module (SAMs CME) requirements.
ASCP designates these live activities for a maximum of 0.5 CMLE credit. These activities meet CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a .m. to 6 p.m. Eastern Time
Method of Participation
To complete the activity and receive credit, the participant must complete the online course. CME certificates will be provided on-line.
Funded by an independent educational grant from AstraZeneca.